COc1cccc(CNC(=O)Cn2cc3c(n2)-c2c(oc(C(=O)N4CCCC4)c2C)CC3)c1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?